Bacterial and fungal pathogens

Bacterial and fungal pathogens is not a canonical molecule or receptor, but rather a broad category encompassing diverse microorganisms responsible for infectious diseases in humans. This term covers multiple species—such as bacteria (e.g., *Staphylococcus aureus*, *Escherichia coli*) and fungi (e.g., *Candida albicans*, *Aspergillus fumigatus*)—that trigger infections including sepsis and other systemic or localized conditions[1][3]. These pathogens are clinically relevant due to their role in infection and antimicrobial resistance. They are not a singular drug target, but rather the organisms themselves are targets of therapeutic strategies including antibiotics for bacteria and antifungal agents (such as azoles, echinocandins, and polyenes) for fungi[4][5]. Research in the field uses a variety of biomarkers (e.g., IL6, SOCS3, IRG1) to distinguish host response to these infections[1]. The use of "Bacterial and fungal pathogens" as a molecule or receptor is incorrect; it refers to a disease-causing group, not a distinct, actionable molecular entity[1][4].

Not applicable as 'Bacterial and fungal pathogens' is a broad category of organisms, not a specific molecular target with a defined mechanism of action that drugs directly modulate.